Company profile

Apasomics company profile

Apasomics is a biotechnology company pioneering bone-targeted drug delivery to transform the treatment of osteoporosis, and skeletal disorders. Our apasome-based nanocarriers deliver bisphosphonates directly to the bone, ensuring maximum efficacy while minimizing side effects. By combining nanotechnology, precision medicine, and advanced drug delivery, we aim to revolutionize bone health treatments—enhancing therapeutic outcomes, improving patient quality of life, and opening new frontiers in regenerative medicine.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2024-10-01

Headquarters

Headquarters
Anhelivka, Ternopil, Ukraine
Country code
UA
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Pre Seed / 2024-12-01
Last equity funding
Pre Seed
Investors
1

Founders and investors

Investors

GRID EXPONENTIAL

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.